https://m2.mtmt.hu/ hun 2026-05-25 05:43 JournalArticle 32130659 APPROVED true 0 false 2026-05-21T01:14:50.978+0000 2025-11-21T16:17:41.391+0000 2021-08-12T18:12:11.683+0000 true 10015206 Áncsán Gizella /api/admin/10015206 Admin Áncsán Gizella (SE admin) true 10015206 2026-01-16T11:01:22.010+0000 2026-01-16T11:01:22.010+0000 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 1134514 Survey paper true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/1134514 Összefoglaló cikk SubType Összefoglaló cikk (Folyóiratcikk) 102 true 1134514 true 1 /api/category/1 Category Tudományos true 1 Meehan, Gavin R true true /api/journal/383 REVIEWED ANNALS OF THE RHEUMATIC DISEASES 0003-4967 1468-2060 true false 383 false 383 true 0003-4967 1468-2060 Journal FOREIGN 80 10 1268 1277 1268 10 2021 true 2021 true true true false true false NONE 2026-05-21 false 27 0 27 25 1 27 27 27 27 27 27 25 25 25 2 0 27 25 27 25 0 5 5 Folyóiratcikk Journal Article 24 27 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2022 0 5 3 5 3 2023 0 7 7 7 7 2024 0 7 7 7 7 2025 0 7 7 7 7 2026 0 1 1 1 1 D1 false false false false 2021-11-10T19:12:26.998+0000 Genetikai, Sejt- és Immunbiológiai Intézet (SE / AOK / I); Reumatológiai és Klinikai Immunológiai Tanszék (SE / AOK / K / BOK) 1 16 2 13 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 97020899 /api/authorship/97020899 Meehan, Gavin R 1 0.07692308 true false false Meehan Gavin R true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97020900 /api/authorship/97020900 Thomas, Ranjeny 2 0.07692308 false false false Thomas Ranjeny true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97020901 /api/authorship/97020901 Al Khabouri, Shaima 3 0.07692308 false false false Al Khabouri Shaima true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97020902 /api/authorship/97020902 Wehr, Pascale 4 0.07692308 false false false Wehr Pascale true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97020903 /api/authorship/97020903 Hilkens, Catharien MU 5 0.07692308 false false false Hilkens Catharien MU true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97020904 /api/authorship/97020904 Wraith, David C 6 0.07692308 false false false Wraith David C true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97020905 /api/authorship/97020905 Sieghart, Daniela 7 0.07692308 false false false Sieghart Daniela true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97020906 /api/authorship/97020906 Bonelli, Michael 8 0.07692308 false false false Bonelli Michael true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97020907 /api/authorship/97020907 Nagy, György [Nagy, György (Immunológia), szerző] Genetikai, Sejt- és Immunbiológiai Intézet (SE / AOK / I); Reumatológiai és Klinikai Immunológiai Tanszék (SE / AOK / K / BOK) 9 0.077 false false false Author 10025749 /api/author/10025749 Nagy György (Immunológia) Nagy György true 10025749 true Nagy György true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97020908 /api/authorship/97020908 Garside, Paul 10 0.07692308 false false false Garside Paul true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97020909 /api/authorship/97020909 Tough, David F 11 0.07692308 false false false Tough David F true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97020910 /api/authorship/97020910 Lewis, Huw D 12 0.07692308 false false false Lewis Huw D true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 97020911 /api/authorship/97020911 Brewer, James M ✉ 13 0.077 false true true Brewer James M true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 19086093 /api/publicationidentifier/19086093 DOI: 10.1136/annrheumdis-2021-220043 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.1136/annrheumdis-2021-220043 https://doi.org/10.1136/annrheumdis-2021-220043 false true PublicationIdentifier 19624058 /api/publicationidentifier/19624058 WoS: 000698436800021 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 000698436800021 https://www.webofscience.com/wos/woscc/full-record/000698436800021 false true PublicationIdentifier 20129156 /api/publicationidentifier/20129156 Scopus: 85116953665 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85116953665 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85116953665 true true PublicationIdentifier 19317293 /api/publicationidentifier/19317293 PubMed: 34380700 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 34380700 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34380700&dopt=Abstract false true PublicationIdentifier 19086094 /api/publicationidentifier/19086094 Egyéb URL: https://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2021-220043 PlainSource 40 /api/publicationsource/40 Egyéb URL PublicationSourceType 10006 /api/publicationsourcetype/10006 Link true true true Egyéb URL Other URL @@@ true true 40 true https://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2021-220043 https://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2021-220043 false true Classification 12215 /api/classification/12215 Klinikai orvostan true true SjrRating 11195757 /api/sjrrating/11195757 sjr:D1 (2021) Scopus - Biochemistry, Genetics and Molecular Biology (miscellaneous) ANNALS OF THE RHEUMATIC DISEASES 0003-4967 1468-2060 7 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 1301 /api/classificationexternal/1301 Scopus - Biochemistry, Genetics and Molecular Biology (miscellaneous) true 1301 true D1 DIRECT true true Reference 22160391 /api/reference/22160391 1. , DOI: 10.1136/annrheumdis-2011-200990 1 10.1136/annrheumdis-2011-200990 false true Reference 22160392 /api/reference/22160392 2. , DOI: 10.1136/annrheumdis-2016-209846 2 10.1136/annrheumdis-2016-209846 false true Reference 22160393 /api/reference/22160393 3. Ten Brinck 2017: The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia., Rheumatology, 56, p. 2145, DOI: 10.1093/rheumatology/kex340 3 10.1093/rheumatology/kex340 false true Reference 22160394 /api/reference/22160394 4. , DOI: 10.1136/rmdopen-2017-000479 4 10.1136/rmdopen-2017-000479 false true Reference 22160395 /api/reference/22160395 5. , DOI: 10.1136/rmdopen-2018-000748 5 10.1136/rmdopen-2018-000748 false true Reference 22160396 /api/reference/22160396 6. Al-Laith 2019: Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol., Trials, 20, DOI: 10.1186/s13063-019-3403-7 6 10.1186/s13063-019-3403-7 false true Reference 22160397 /api/reference/22160397 7. Bos 2010: Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study., Ann Rheum Dis, 69, p. 490 LP, DOI: 10.1136/ard.2008.105759 7 10.1136/ard.2008.105759 false true Reference 22160398 /api/reference/22160398 8. , DOI: 10.1136/rmdopen-2015-000057 8 10.1136/rmdopen-2015-000057 false true Reference 22160399 /api/reference/22160399 9. , DOI: 10.1186/s13075-015-0707-1 9 10.1186/s13075-015-0707-1 false true Reference 22160400 /api/reference/22160400 10. Benson 2018: Model answers: rational application of murine models in arthritis research., Eur J Immunol, 48, p. 32, DOI: 10.1002/eji.201746938 10 10.1002/eji.201746938 false true Reference 22160401 /api/reference/22160401 11. , DOI: 10.1002/art.11229 11 10.1002/art.11229 false true Reference 22160402 /api/reference/22160402 12. Bendele 2001: Animal models of rheumatoid arthritis., J Musculoskelet & neuronal Interact, 1, p. 377 12 false true Reference 22160403 /api/reference/22160403 13. , DOI: 10.1002/eji.200939578 13 10.1002/eji.200939578 false true Reference 22160404 /api/reference/22160404 14. Derksen 2017: The role of autoantibodies in the pathophysiology of rheumatoid arthritis., Semin Immunopathol, 39, p. 437, DOI: 10.1007/s00281-017-0627-z 14 10.1007/s00281-017-0627-z false true Reference 22160405 /api/reference/22160405 15. , DOI: 10.1056/NEJMra1004965 15 10.1056/NEJMra1004965 false true Reference 22160406 /api/reference/22160406 16. , DOI: 10.1038/nri2094 16 10.1038/nri2094 false true Reference 22160407 /api/reference/22160407 17. Baka Z , Buzás E , Nagy G . Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Res Ther 2009;11:238. doi:10.1186/ar2751, DOI: 10.1186/ar2751 17 10.1186/ar2751 false true Reference 22160408 /api/reference/22160408 18. , DOI: 10.1016/j.jbspin.2012.01.008 18 10.1016/j.jbspin.2012.01.008 false true Reference 22160409 /api/reference/22160409 19. , DOI: 10.1084/jem.20041758 19 10.1084/jem.20041758 false true Reference 22160410 /api/reference/22160410 20. Rehaume 2014: Zap-70 genotype disrupts the relationship between microbiota and host, leading to spondyloarthritis and ileitis in SKG mice., Arthritis Rheumatol, 66, p. 2780, DOI: 10.1002/art.38773 20 10.1002/art.38773 false true Reference 22160411 /api/reference/22160411 21. , DOI: 10.4049/jimmunol.1000848 21 10.4049/jimmunol.1000848 false true Reference 22160412 /api/reference/22160412 22. , DOI: 10.1023/B:JOCI.0000040919.16739.44 22 10.1023/B:JOCI.0000040919.16739.44 false true Reference 22160413 /api/reference/22160413 23. Sakaguchi S , Takahashi T , Hata H , et al . Skg mice, a new genetic model of rheumatoid arthritis. Arthritis Res Ther 2003;5:10. doi:10.1186/ar811, DOI: 10.1186/ar811 23 10.1186/ar811 false true Reference 22160414 /api/reference/22160414 24. , DOI: 10.1002/art.1780290114 24 10.1002/art.1780290114 false true Reference 22160415 /api/reference/22160415 25. Holmdahl 1985: Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II., Clin Exp Immunol, 62, p. 639 25 false true Reference 22160416 /api/reference/22160416 26. Tong 2018: A shared epitope of collagen type XI and type II is recognized by pathogenic antibodies in mice and humans with arthritis., Front Immunol, 9, DOI: 10.3389/fimmu.2018.00451 26 10.3389/fimmu.2018.00451 false true Reference 22160417 /api/reference/22160417 27. , DOI: 10.4049/jimmunol.173.1.151 27 10.4049/jimmunol.173.1.151 false true Reference 22160418 /api/reference/22160418 28. , DOI: 10.1002/art.1780200314 28 10.1002/art.1780200314 false true Reference 22160419 /api/reference/22160419 29. , DOI: 10.1002/art.30413 29 10.1002/art.30413 false true Reference 22160420 /api/reference/22160420 30. , DOI: 10.1136/ard.2008.089300 30 10.1136/ard.2008.089300 false true Reference 22160421 /api/reference/22160421 31. , DOI: 10.4049/jimmunol.182.2.963 31 10.4049/jimmunol.182.2.963 false true Reference 22160422 /api/reference/22160422 32. , DOI: 10.4049/jimmunol.0903951 32 10.4049/jimmunol.0903951 false true Reference 22160423 /api/reference/22160423 33. , DOI: 10.1002/art.20296 33 10.1002/art.20296 false true Reference 22160424 /api/reference/22160424 34. , DOI: 10.1016/S0140-6736(17)31472-1 34 10.1016/S0140-6736(17)31472-1 false true Reference 22160425 /api/reference/22160425 35. Olasz 2012: T cell receptor (TCR) signal strength controls arthritis severity in proteoglycan-specific TCR transgenic mice., Clin Exp Immunol, 167, p. 346, DOI: 10.1111/j.1365-2249.2011.04506.x 35 10.1111/j.1365-2249.2011.04506.x false true Reference 22160426 /api/reference/22160426 36. , DOI: 10.1186/ar2954 36 10.1186/ar2954 false true Reference 22160427 /api/reference/22160427 37. Mandala 2002: Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists., Science, 296, p. 346 LP, DOI: 10.1126/science.1070238 37 10.1126/science.1070238 false true Reference 22160428 /api/reference/22160428 38. , DOI: 10.1038/nature02284 38 10.1038/nature02284 false true Reference 22160429 /api/reference/22160429 39. , DOI: 10.1038/ni1545 39 10.1038/ni1545 false true Reference 22160430 /api/reference/22160430 40. Wood 1994: Expression of class II major histocompatibility antigens by keratinocytes in cutaneous T cell lymphoma., Int J Dermatol, 33, p. 346, DOI: 10.1111/j.1365-4362.1994.tb01066.x 40 10.1111/j.1365-4362.1994.tb01066.x false true Reference 22160431 /api/reference/22160431 41. Sheen-Chen 1994: An evaluation of the prognostic significance of HLA-DR expression in axillary-node-negative breast cancer., Surgery, 116, p. 510 41 false true Reference 22160432 /api/reference/22160432 42. Svendsen 2004: Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice., J Immunol, 173, p. 7037 LP, DOI: 10.4049/jimmunol.173.11.7037 42 10.4049/jimmunol.173.11.7037 false true Reference 22160433 /api/reference/22160433 43. , DOI: 10.1002/art.1780370919 43 10.1002/art.1780370919 false true Reference 22160434 /api/reference/22160434 44. O'Neill 2005: Antigen-Specific B cells are required as APCS and autoantibody-producing cells for induction of severe autoimmune arthritis., J Immunol, 174, p. 3781 LP, DOI: 10.4049/jimmunol.174.6.3781 44 10.4049/jimmunol.174.6.3781 false true Reference 22160435 /api/reference/22160435 45. Sun 2018: B cells inhibit bone formation in rheumatoid arthritis by suppressing osteoblast differentiation., Nat Commun, 9, DOI: 10.1038/s41467-018-07626-8 45 10.1038/s41467-018-07626-8 false true Reference 22160436 /api/reference/22160436 46. Miura 2019: A subpopulation of synovial fibroblasts leads to Osteochondrogenesis in a mouse model of chronic inflammatory rheumatoid arthritis., JBMR Plus, 3, DOI: 10.1002/jbm4.10132 46 10.1002/jbm4.10132 false true Reference 22160437 /api/reference/22160437 47. , DOI: 10.1016/j.immuni.2017.02.006 47 10.1016/j.immuni.2017.02.006 false true Reference 22160438 /api/reference/22160438 48. Holoshitz 2010: The rheumatoid arthritis HLA-DRB1 shared epitope., Rheumatology, 22, p. 293 48 false true Reference 22160439 /api/reference/22160439 49. , DOI: 10.7326/0003-4819-117-10-801 49 10.7326/0003-4819-117-10-801 false true Reference 22160440 /api/reference/22160440 50. Bhayani 1991: The role of polymorphic amino acids of the MHC molecule in the selection of the T cell repertoire., J Immunol, 146, p. 1093 50 false true Reference 22160441 /api/reference/22160441 51. , DOI: 10.4049/jimmunol.164.4.1695 51 10.4049/jimmunol.164.4.1695 false true Reference 22160442 /api/reference/22160442 52. , DOI: 10.1073/pnas.95.24.14447 52 10.1073/pnas.95.24.14447 false true Reference 22160443 /api/reference/22160443 53. , DOI: 10.1002/art.1780390312 53 10.1002/art.1780390312 false true Reference 22160444 /api/reference/22160444 54. , DOI: 10.1136/annrheumdis-2011-200612 54 10.1136/annrheumdis-2011-200612 false true Reference 22160445 /api/reference/22160445 55. , DOI: 10.1073/pnas.85.4.1179 55 10.1073/pnas.85.4.1179 false true Reference 22160446 /api/reference/22160446 56. , DOI: 10.1002/art.1780390606 56 10.1002/art.1780390606 false true Reference 22160447 /api/reference/22160447 57. Benham 2015: Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients., Sci Transl Med, 7, p. 290ra87 LP, DOI: 10.1126/scitranslmed.aaa9301 57 10.1126/scitranslmed.aaa9301 false true Reference 22160448 /api/reference/22160448 58. Brand 2001: I-Aq and I-Ap bind and present similar antigenic peptides despite differing in their ability to mediate susceptibility to autoimmune arthritis., Autoimmunity, 34, p. 133, DOI: 10.3109/08916930109001961 58 10.3109/08916930109001961 false true Reference 22160449 /api/reference/22160449 59. , DOI: 10.1002/art.24635 59 10.1002/art.24635 false true Reference 22160450 /api/reference/22160450 60. Kato 1997: T cell clonality in synovial fluid of a patient with rheumatoid arthritis: persistent but fluctuant oligoclonal T cell expansions., J Immunol, 159, p. 5143 60 false true Reference 22160451 /api/reference/22160451 61. , DOI: 10.1093/rheumatology/39.11.1189 61 10.1093/rheumatology/39.11.1189 false true Reference 22160452 /api/reference/22160452 62. , DOI: 10.1007/s00296-010-1402-9 62 10.1007/s00296-010-1402-9 false true Reference 22160453 /api/reference/22160453 63. Monserrat 2019: The abnormal CD4+T lymphocyte subset distribution and Vbeta repertoire in new-onset rheumatoid arthritis can be modulated by methotrexate Treament., Cells, 8, DOI: 10.3390/cells8080871 63 10.3390/cells8080871 false true Reference 22160454 /api/reference/22160454 64. , DOI: 10.1136/annrheumdis-2012-202055 64 10.1136/annrheumdis-2012-202055 false true Reference 22160455 /api/reference/22160455 65. , DOI: 10.4049/jimmunol.171.7.3493 65 10.4049/jimmunol.171.7.3493 false true Reference 22160456 /api/reference/22160456 66. , DOI: 10.1002/art.20289 66 10.1002/art.20289 false true Reference 22160457 /api/reference/22160457 67. , DOI: 10.1084/jem.180.2.517 67 10.1084/jem.180.2.517 false true Reference 22160458 /api/reference/22160458 68. , DOI: 10.1002/eji.1830230530 68 10.1002/eji.1830230530 false true Reference 22160459 /api/reference/22160459 69. , DOI: 10.1002/eji.1830211202 69 10.1002/eji.1830211202 false true Reference 22160460 /api/reference/22160460 70. , DOI: 10.4049/jimmunol.1000416 70 10.4049/jimmunol.1000416 false true Reference 22160461 /api/reference/22160461 71. Al Khabouri S , Benson RA , Prendergast CT , et al . TCRβ sequencing reveals spatial and temporal evolution of clonal CD4 T cell responses in a breach of tolerance model of inflammatory arthritis. Front Immunol 2021;12:1399. doi:10.3389/fimmu.2021.669856, DOI: 10.3389/fimmu.2021.669856 71 10.3389/fimmu.2021.669856 false true Reference 22160462 /api/reference/22160462 72. , DOI: 10.3389/fimmu.2018.00350 72 10.3389/fimmu.2018.00350 false true Reference 22160463 /api/reference/22160463 73. Domogalla 2017: Tolerance through education: how tolerogenic dendritic cells shape immunity., Front Immunol, 8, DOI: 10.3389/fimmu.2017.01764 73 10.3389/fimmu.2017.01764 false true Reference 22160464 /api/reference/22160464 74. , DOI: 10.1016/S1525-0016(02)90712-4 74 10.1016/S1525-0016(02)90712-4 false true Reference 22160465 /api/reference/22160465 75. , DOI: 10.1002/art.27756 75 10.1002/art.27756 false true Reference 22160466 /api/reference/22160466 76. , DOI: 10.1002/eji.200838987 76 10.1002/eji.200838987 false true Reference 22160467 /api/reference/22160467 77. , DOI: 10.1002/art.22655 77 10.1002/art.22655 false true Reference 22160468 /api/reference/22160468 78. Schinnerling 2019: Humanized mouse models of rheumatoid arthritis for studies on immunopathogenesis and preclinical testing of cell-based therapies., Front Immunol, 10, DOI: 10.3389/fimmu.2019.00203 78 10.3389/fimmu.2019.00203 false true Reference 22160469 /api/reference/22160469 79. , DOI: 10.1084/jem.175.4.925 79 10.1084/jem.175.4.925 false true Reference 22160470 /api/reference/22160470 80. Albani 2011: Induction of immune tolerance in the treatment of rheumatoid arthritis., Nat Rev Rheumatol, 7, p. 272, DOI: 10.1038/nrrheum.2011.36 80 10.1038/nrrheum.2011.36 false true Reference 22160471 /api/reference/22160471 81. Pearce 2019: Antigen-Specific immunotherapy with thyrotropin receptor peptides in Graves' hyperthyroidism: a phase I study., Thyroid, 29, p. 1003, DOI: 10.1089/thy.2019.0036 81 10.1089/thy.2019.0036 false true Reference 22160472 /api/reference/22160472 82. , DOI: 10.1002/ana.22219 82 10.1002/ana.22219 false true Reference 22160473 /api/reference/22160473 83. Walczak 2013: Transdermal application of myelin peptides in multiple sclerosis treatment., JAMA Neurol, 70, p. 1105, DOI: 10.1001/jamaneurol.2013.3022 83 10.1001/jamaneurol.2013.3022 false true Reference 22160474 /api/reference/22160474 84. , DOI: 10.1146/annurev.iy.11.040193.003501 84 10.1146/annurev.iy.11.040193.003501 false true Reference 22160475 /api/reference/22160475 85. , DOI: 10.1212/NXI.0000000000000093 85 10.1212/NXI.0000000000000093 false true Reference 22160476 /api/reference/22160476 86. , DOI: 10.1038/nature16962 86 10.1038/nature16962 false true Reference 22160477 /api/reference/22160477 87. Jansson 2018: Immunotherapy with Apitopes blocks the immune response to TSH receptor in HLA-DR transgenic mice., Endocrinology, 159, p. 3446, DOI: 10.1210/en.2018-00306 87 10.1210/en.2018-00306 false true Reference 22160478 /api/reference/22160478 88. , DOI: 10.1038/15525 88 10.1038/15525 false true Reference 22160479 /api/reference/22160479 89. De Souza 2018: ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs., Neurol Ther, 7, p. 103, DOI: 10.1007/s40120-018-0094-z 89 10.1007/s40120-018-0094-z false true Reference 22160480 /api/reference/22160480 90. , DOI: 10.1038/ni756 90 10.1038/ni756 false true Reference 22160481 /api/reference/22160481 91. , DOI: 10.1038/ncomms5741 91 10.1038/ncomms5741 false true Reference 22160482 /api/reference/22160482 92. Rosado-Sánchez 2020: Building a CAR-Treg: going from the basic to the luxury model., Cell Immunol, 358, DOI: 10.1016/j.cellimm.2020.104220 92 10.1016/j.cellimm.2020.104220 false true Reference 22160483 /api/reference/22160483 93. , DOI: 10.3389/fimmu.2018.02359 93 10.3389/fimmu.2018.02359 false true Reference 22160484 /api/reference/22160484 94. Sadelain 2017: Cd19 CAR T cells., Cell, 171, DOI: 10.1016/j.cell.2017.12.002 94 10.1016/j.cell.2017.12.002 false true Reference 22160485 /api/reference/22160485 95. Raffin 2018: Development of citrullinated-vimentin-specific CAR for targeting Tregs to treat autoimmune rheumatoid arthritis., J Immunol, 200, p. 176.17 LP 95 false true Reference 22160486 /api/reference/22160486 96. Chan 2020: Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cells., Clin Transl Immunology, 9, p. e1157, DOI: 10.1002/cti2.1157 96 10.1002/cti2.1157 false true Reference 22160487 /api/reference/22160487 97. Nagler-Anderson 1986: Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen., Proc Natl Acad Sci U S A, 83, p. 7443 LP, DOI: 10.1073/pnas.83.19.7443 97 10.1073/pnas.83.19.7443 false true Reference 22160488 /api/reference/22160488 98. Thompson 1986: Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats., Clin Exp Immunol, 64, p. 581 98 false true Reference 22160489 /api/reference/22160489 99. , DOI: 10.1002/1529-0131(199802)41:2&lt;290::AID-ART13&gt;3.0.CO;2-R 99 10.1002/1529-0131(199802)41:2&lt;290::AID-ART13&gt;3.0.CO;2-R false true Reference 22160490 /api/reference/22160490 100. , DOI: 10.1002/1529-0131(199906)42:6&lt;1204::AID-ANR17&gt;3.0.CO;2-U 100 10.1002/1529-0131(199906)42:6&lt;1204::AID-ANR17&gt;3.0.CO;2-U false true Reference 22160491 /api/reference/22160491 101. Wei 2009: A multicenter, double-blind, randomized, controlled phase III clinical trial of chicken type II collagen in rheumatoid arthritis., Arthritis Res Ther, 11, p. R180, DOI: 10.1186/ar2870 101 10.1186/ar2870 false true Reference 22160492 /api/reference/22160492 102. , DOI: 10.1111/j.1600-065X.2011.01017.x 102 10.1111/j.1600-065X.2011.01017.x false true Reference 22160493 /api/reference/22160493 103. , DOI: 10.1136/ard.2010.148551 103 10.1136/ard.2010.148551 false true Reference 22160494 /api/reference/22160494 104. , DOI: 10.1038/icb.2009.46 104 10.1038/icb.2009.46 false true Reference 22160495 /api/reference/22160495 105. , DOI: 10.4049/jimmunol.0802972 105 10.4049/jimmunol.0802972 false true Reference 22160496 /api/reference/22160496 106. Galea 2019: PD-L1- and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease., JCI Insight, 4, DOI: 10.1172/jci.insight.126025 106 10.1172/jci.insight.126025 false true Reference 22160497 /api/reference/22160497 107. , DOI: 10.1016/S1074-7613(00)80045-X 107 10.1016/S1074-7613(00)80045-X false true Reference 22160498 /api/reference/22160498 108. Plock 2013: Perspectives on the use of mesenchymal stem cells in vascularized composite allotransplantation., Front Immunol, 4, DOI: 10.3389/fimmu.2013.00175 108 10.3389/fimmu.2013.00175 false true Reference 22160499 /api/reference/22160499 109. , DOI: 10.1172/JCI11490 109 10.1172/JCI11490 false true Reference 22160500 /api/reference/22160500 110. Piccirillo 2020: Transcriptional and translational control of Foxp3+ regulatory T cell functional adaptation to inflammation., Curr Opin Immunol, 67, p. 27, DOI: 10.1016/j.coi.2020.07.006 110 10.1016/j.coi.2020.07.006 false true Reference 22160501 /api/reference/22160501 111. , DOI: 10.1038/nm.3432 111 10.1038/nm.3432 false true Reference 22160502 /api/reference/22160502 112. Graßhoff 2021: Low-Dose IL-2 therapy in autoimmune and rheumatic diseases., Front Immunol, 12, DOI: 10.3389/fimmu.2021.648408 112 10.3389/fimmu.2021.648408 false true Reference 22160503 /api/reference/22160503 113. Nomoto 1992: Interference with cyclophosphamide-induced skin allograft tolerance by cyclosporin A., J Immunol, 149, p. 2668 LP 113 false true Reference 22160504 /api/reference/22160504 114. , DOI: 10.1038/11341 114 10.1038/11341 false true Reference 22160505 /api/reference/22160505 115. , DOI: 10.1182/blood-2006-01-0329 115 10.1182/blood-2006-01-0329 false true Reference 22160506 /api/reference/22160506 116. Hijnen 2009: Cyclosporin A reduces CD4(+)CD25(+) regulatory T-cell numbers in patients with atopic dermatitis., J Allergy Clin Immunol, 124, p. 856, DOI: 10.1016/j.jaci.2009.07.056 116 10.1016/j.jaci.2009.07.056 false true Reference 22160507 /api/reference/22160507 117. , DOI: 10.1016/j.transproceed.2009.08.043 117 10.1016/j.transproceed.2009.08.043 false true Reference 22160508 /api/reference/22160508 118. , DOI: 10.4049/jimmunol.177.10.7346 118 10.4049/jimmunol.177.10.7346 false true Reference 22160509 /api/reference/22160509 119. , DOI: 10.1084/jem.20052016 119 10.1084/jem.20052016 false true Reference 22160510 /api/reference/22160510 120. , DOI: 10.4049/jimmunol.177.2.863 120 10.4049/jimmunol.177.2.863 false true Reference 22160511 /api/reference/22160511 121. Li 2020: Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects., Mol Cancer, 19, DOI: 10.1186/s12943-020-01234-1 121 10.1186/s12943-020-01234-1 false true Reference 22160512 /api/reference/22160512 122. , DOI: 10.1136/bmjopen-2019-030309 122 10.1136/bmjopen-2019-030309 false true Reference 22160513 /api/reference/22160513 123. Bessis 2017: Arthritis models: usefulness and interpretation., Semin Immunopathol, 39, p. 469, DOI: 10.1007/s00281-017-0622-4 123 10.1007/s00281-017-0622-4 false true /api/publication/32130659 Meehan Gavin R et al. Preclinical models of arthritis for studying immunotherapy and immune tolerance. (2021) ANNALS OF THE RHEUMATIC DISEASES 0003-4967 1468-2060 80 10 1268-1277<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" >Meehan Gavin R </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Thomas Ranjeny </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Al Khabouri Shaima </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Wehr Pascale </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Hilkens Catharien MU </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Wraith David C </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Sieghart Daniela </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Bonelli Michael </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10025749"><a href="/gui2/?type=authors&mode=browse&sel=10025749" target="_blank">Nagy György (<span class="authorship-author-name">Nagy György</span> <span class="authorAux-mtmt"> Immunológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Genetikai, Sejt- és Immunbiológiai Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Belgyógyászati és Onkológiai Klinika">BOK</span>/Reumatológiai és Klinikai Immunológiai Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Garside Paul </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Tough David F </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Lewis Huw D </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Brewer James M ✉ </span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;32130659" target="_blank">Preclinical models of arthritis for studying immunotherapy and immune tolerance</a></div> <div> <span class="journal-title">ANNALS OF THE RHEUMATIC DISEASES</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/0003-4967">0003-4967</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1468-2060">1468-2060</a>)</span>: <span class="journal-volume">80</span> <span class="journal-issue">10</span> <span class="page"> pp 1268-1277 </span> <span class="year">(2021)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1136/annrheumdis-2021-220043" target="_blank" href="https://doi.org/10.1136/annrheumdis-2021-220043"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000698436800021" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000698436800021"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85116953665" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85116953665"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="34380700" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34380700&dopt=Abstract"> PubMed </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:black" title="https://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2021-220043" target="_blank" href="https://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2021-220043"> Egyéb URL </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Biochemistry, Genetics and Molecular Biology (miscellaneous)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Immunology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Immunology and Allergy&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Rheumatology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 27</span> | Független: 25 | Függő: 2 | Nem jelölt: 0 | WoS jelölt: 27 | Scopus jelölt:&nbsp;27 | WoS/Scopus jelölt:&nbsp;27 | DOI jelölt:&nbsp;27 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;32130659&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 5 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 32130659</span> | <span class="status-data status-APPROVED"> Nyilvános </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Összefoglaló cikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="lastModified">Utolsó módosítás: 2025.11.21. 17:17 Pécsi Éva (MTMT Közp 2,3, admin) </div> </div></div>